TDP ‐ 43 mutation in familial amyotrophic lateral sclerosis

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617

Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis

Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576

TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.093 · Cited by 2,732

α-Synuclein is phosphorylated in synucleinopathy lesions

Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M. S., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 2,174

Pathological TDP‐43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations

Mackenzie, I. R. A., Bigio, E. H., Ince, P. G., Geser, F., Neumann, M., Cairns, N. J., Kwong, L. K., Forman, M. S., Ravits, J., Stewart, H., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21147 · Cited by 992

TDP-43 Binds Heterogeneous Nuclear Ribonucleoprotein A/B through Its C-terminal Tail

Buratti, E., Brindisi, A., Giombi, M., Tisminetzky, S. G., Ayala, Y. M., & Baralle, F. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505557200 · Cited by 474

Progranulin Mediates Caspase-Dependent Cleavage of TAR DNA Binding Protein-43

Zhang, Y., Xu, Y.-F., Dickey, C. A., Buratti, E., Baralle, F. E., Bailey, R. M., Pickering-Brown, S. M., Dickson, D. W., & Petrucelli, L. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3421-07.2007 · Cited by 371

UBIQUITIN-IMMUNOREACTIVE INTRANEURONAL INCLUSIONS IN AMYOTROPHIC LATERAL SCLEROSIS

Leigh, P. N., Whitwell, H., Garofalo, O., Buller, J., Swash, M., Martin, J., Gallo, J., Weller, R. O., & Anderton, B. H. (1991) · Brain · doi:10.1093/brain/114.2.775 · Cited by 331

TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation

Tan, C., Eguchi, H., Tagawa, A., Onodera, O., Iwasaki, T., Tsujino, A., Nishizawa, M., Kakita, A., & Takahashi, H. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0206-9 · Cited by 298

TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease

Kwong, L. K., Neumann, M., Sampathu, D. M., Lee, V. M. ‐., & Trojanowski, J. Q. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0226-5 · Cited by 231

Sporadic amyotrophic lateral sclerosis: Widespread multisystem degeneration with TDP‐43 pathology in a patient after long‐term survival on a respirator

Nishihira, Y., Tan, C., Toyoshima, Y., Yonemochi, Y., Kondo, H., Nakajima, T., & Takahashi, H. (2009) · Neuropathology · doi:10.1111/j.1440-1789.2008.00999.x · Cited by 39

Mutation-dependent aggregation and toxicity in a Drosophila model for UBQLN2-associated ALS

Kim, S. H., Stiles, S., Feichtmeier, J., Ramesh, N., Zhan, L., Scalf, M., Smith, L. M., Pandey, U. B., & Tibbetts, R. S. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx403 · Cited by 37

Tar DNA-binding protein-43 (TDP-43) regulates axon growth in vitro and in vivo

Tripathi, V. B., Baskaran, P., Shaw, C. E., & Guthrie, S. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.01.004 · Cited by 41

Biochemical and histopathological alterations in TAR DNA‐binding protein‐43 after acute ischemic stroke in rats

Kanazawa, M., Kakita, A., Igarashi, H., Takahashi, T., Kawamura, K., Takahashi, H., Nakada, T., Nishizawa, M., & Shimohata, T. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06860.x · Cited by 38

The diagnosis of Amyotrophic lateral sclerosis in 2010.

Silani, V., Messina, S., Poletti, B., Morelli, C., Doretti, A., Ticozzi, N., & Maderna, L. (2011) · PubMed · doi:10.4449/aib.v149i1.1260 · Cited by 38

CUL2-mediated clearance of misfolded TDP-43 is paradoxically affected by VHL in oligodendrocytes in ALS

Uchida, T., Tamaki, Y., Ayaki, T., Shodai, A., Kaji, S., Morimura, T., Banno, Y., Nishitsuji, K., Sakashita, N., Maki, T., et al. (2016) · Scientific Reports · doi:10.1038/srep19118 · Cited by 41

Recapitulation of Pathological TDP-43 Features in Immortalized Lymphocytes from Sporadic ALS Patients

Posa, D., Martínez‐González, L., Bartolomé, F. B., Nagaraj, S., Porras, G., Martı́nez, A., & Martín‐Requero, Á. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1249-8 · Cited by 37

Disease-modifying effects of metabolic perturbations in ALS/FTLD

Jawaid, A., Khan, R., Polymenidou, M., & Schulz, P. E. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0294-0 · Cited by 37

Amyotrophic Lateral Sclerosis Genes in Drosophila melanogaster

Layalle, S., They, L., Ourghani, S., Raoul, C., & Soustelle, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020904 · Cited by 36

Protein clearing pathways in ALS.

Ferrucci, M., Fulceri, F., Toti, L., Soldani, P., Siciliano, G., Paparelli, A., & Fornai, F. (2011) · PubMed · doi:10.4449/aib.v149i1.1258 · Cited by 35

Advances and challenges in understanding the multifaceted pathogenesis of amyotrophic lateral sclerosis

Laferrière, F., & Polymenidou, M. (2015) · Swiss Medical Weekly · doi:10.4414/smw.2015.14054 · Cited by 43

Non-genetically modified models exhibit TARDBP mRNA increase due to perturbed TDP-43 autoregulation

Sugai, A., Kato, T., Koyama, A., Koike, Y. M., Konno, T., Ishihara, T., & Onodera, O. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104534 · Cited by 34

Conserved Acidic Amino Acid Residues in a Second RNA Recognition Motif Regulate Assembly and Function of TDP-43

Shodai, A., Ido, A., Fujiwara, N., Ayaki, T., Morimura, T., Oono, M., Uchida, T., Takahashi, R., Ito, H., & Urushitani, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052776 · Cited by 36

Different clinical and neuropathologic phenotypes of familial ALS with A315E TARDBP mutation

Fujita, Y., Ikeda, M., Yanagisawa, T., Senoo, Y., & Okamoto, K. (2011) · Neurology · doi:10.1212/wnl.0b013e318232ab87 · Cited by 35

Novel TARDBP mutations in Nordic ALS patients

Chiang, H., Andersen, P. M., Tysnes, O., Gredal, O., Christensen, P., & Graff, C. (2012) · Journal of Human Genetics · doi:10.1038/jhg.2012.24 · Cited by 36

Amyotrophic lateral sclerosis

Sreedharan, J., Blakeney, I., & Brown, R. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813866-3.00020-5 · Cited by 32

TDP ‐43 pathology in polyglutamine diseases: With reference to amyotrphic lateral sclerosis

Toyoshima, Y., & Takahashi, H. (2013) · Neuropathology · doi:10.1111/neup.12053 · Cited by 33

Recent Advances in RNA Interference Therapeutics for CNS Diseases

Ramachandran, P. S., Keiser, M. S., & Davidson, B. L. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0183-8 · Cited by 31

Enlarging clinical spectrum of FALS with TARDBP gene mutations: S393L variant in an Italian family showing phenotypic variability and relevance for genetic counselling

Origone, P., Caponnetto, C., Poggio, M., Ghiglione, E., Bellone, E., Ferrandes, G., Mancardi, G., & Mandich, P. (2010) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960903165039 · Cited by 30

TDP-43 in skeletal muscle of patients affected with amyotrophic lateral sclerosis

Sorarú, G., Orsetti, V., Buratti, E., Baralle, F. E., Cima, V., Volpe, M., D’Ascenzo, C., Palmieri, A., Koutsikos, K., Pegoraro, E., et al. (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960902810890 · Cited by 29

Biological Spectrum of Amyotrophic Lateral Sclerosis PrionsPreprint

Polymenidou, M., & Cleveland, D. W. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024133 · Cited by 29

Therapeutic Role of Neuregulin 1 Type III in SOD1-Linked Amyotrophic Lateral Sclerosis

Mòdol‐Caballero, G., García-Lareu, B., Verdés, S., Ariza, L., Sánchez-Brualla, I., Brocard, F., Bosch, A., Navarro, X., & Herrando‐Grabulosa, M. (2020) · Neurotherapeutics · doi:10.1007/s13311-019-00811-7 · Cited by 29

The right temporal variant of frontotemporal dementia is not genetically sporadic: a case series

Ulugut Erkoyun, H., van der Lee, S. J., Nijmeijer, B., van Spaendonk, R., Nelissen, A., Scarioni, M., Dijkstra, A., Samancı, B., Gürvit, H., Yıldırım, Z., et al. (2021) · Journal of Alzheimer’s Disease · doi:10.3233/jad-201191 · Cited by 24

ALS skin fibroblasts reveal oxidative stress and ERK1/2-mediated cytoplasmic localization of TDP-43

Romano, N., Catalani, A., Lattante, S., Belardo, A., Proietti, S., Bertini, L., Silvestri, F., Catalani, E., Cervia, D., Zolla, L., et al. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109591 · Cited by 30

Amyotrophic lateral sclerosis

Younger, D. S., & Brown, R. H. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98817-9.00031-4 · Cited by 35

Newly identified ADAR-mediated A-to-I editing positions as a tool for ALS research

Kwak, S., Nishimoto, Y., & Yamashita, T. (2008) · RNA Biology · doi:10.4161/rna.6925 · Cited by 28

TARDBP in amyotrophic lateral sclerosis: identification of a novel variant but absence of copy number variation

Bäumer, D., Parkinson, N., & Talbot, K. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.166512 · Cited by 28

Pathogenic Genome Signatures That Damage Motor Neurons in Amyotrophic Lateral Sclerosis

Yousefian-Jazi, A., Seol, Y., Kim, J., Ryu, H. L., Lee, J.-H., & Ryu, H. (2020) · Cells · doi:10.3390/cells9122687 · Cited by 29

Autophagy-linked FYVE protein (Alfy) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS)

Han, H., Wei, W., Duan, W., Guo, Y., Li, Y., Wang, J., Bi, Y., & Li, C. (2014) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-014-9832-4 · Cited by 26

Drosophila lines with mutant and wild type human TDP-43 replacing the endogenous gene reveals phosphorylation and ubiquitination in mutant lines in the absence of viability or lifespan defects

Chang, J., & Morton, D. B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180828 · Cited by 27

TDP-43 physically interacts with amyotrophic lateral sclerosis-linked mutant CuZn superoxide dismutase

Higashi, S., Tsuchiya, Y., Araki, T., Wada, K., & Kabuta, T. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.09.010 · Cited by 26

Genetic variants in the promoter of TARDBP in sporadic amyotrophic lateral sclerosis

Luquin, N., Yu, B., Saunderson, R. B., Trent, R. J., & Pamphlett, R. (2009) · Neuromuscular Disorders · doi:10.1016/j.nmd.2009.07.005 · Cited by 26

Screening of the TARDBP gene in familial and sporadic amyotrophic lateral sclerosis patients of Chinese origin

Zou, Z., Yu, P., Wang, X., Liu, M., Li, X., & Cui, L. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.03.014 · Cited by 26

Genetic link between Cabeza, a Drosophila homologue of Fused in Sarcoma (FUS), and the EGFR signaling pathway

Shimamura, M., Kyotani, A., Azuma, Y., Yoshida, H., Nguyen, T. B., Mizuta, I., Yoshida, T., Mizuno, T., Nakagawa, M., Tokuda, T., et al. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.06.004 · Cited by 25

Gauging the role and impact of drug interactions and repurposing in neurodegenerative disorders

Khatri, D. K., Kadbhane, A., Patel, M., Nene, S., Atmakuri, S., Srivastava, S., & Singh, S. B. (2021) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2021.100022 · Cited by 25

Significance and limitation of the pathological classification of TDP ‐43 proteinopathy

Arai, T. (2014) · Neuropathology · doi:10.1111/neup.12138 · Cited by 29

Comparison of the clinical and cognitive features of genetically positive ALS patients from the largest tertiary center in Serbia

Marjanović, I. V., Salak‐Djokic, B., Perić, S., Janković, M. Z., Arsenijević, V., Basta, I. Z., Lavrnić, D., Stefanova, E. D., & Stević, Z. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8495-y · Cited by 24

Bunina bodies in motor and non‐motor neurons revisited: A pathological study of an ALS patient after long‐term survival on a respirator

Kimura, T., Jiang, H., Konno, T., Seto, M., Iwanaga, K., Tsujihata, M., Satoh, A., Onodera, O., Kakita, A., & Takahashi, H. (2014) · Neuropathology · doi:10.1111/neup.12105 · Cited by 24

Disease-Associated Mutations of TDP-43 Promote Turnover of the Protein Through the Proteasomal Pathway

Araki, W., Minegishi, S., Motoki, K., Kume, H., Hohjoh, H., Araki, Y. M., & Tamaoka, A. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8644-6 · Cited by 26

Molecular Motor Proteins and Amyotrophic Lateral Sclerosis

Soo, K. Y., Farg, M. A., & Atkin, J. D. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12129057 · Cited by 24

Gene therapy for overexpressing Neuregulin 1 type I in skeletal muscles promotes functional improvement in the SOD1G93A ALS mice

Mòdol‐Caballero, G., Herrando‐Grabulosa, M., García-Lareu, B., Solanes, N., Verdés, S., Osta, R., Francos-Quijorna, I., López‐Vales, R., Calvo, A. C., Bosch, A., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104793 · Cited by 24

Effects of antidepressants on GluR2 Q/R site-RNA editing in modified HeLa cell line

Sawada, J., Yamashita, T., Aizawa, H., Aburakawa, Y., Hasebe, N., & Kwak, S. (2009) · Neuroscience Research · doi:10.1016/j.neures.2009.03.009 · Cited by 23

Potential skin involvement in ALS: revisiting Charcot’s observation – a review of skin abnormalities in ALS

Paré, B., & Gros‐Louis, F. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0004 · Cited by 24

Contribution of TARDBP to Alzheimer's Disease Genetic Etiology

Brouwers, N., Bettens, K., Gijselinck, I., Engelborghs, S., Pickut, B. A., Miegroet, H. V., Montoya, A. G., Mattheijssens, M., Peeters, K., Deyn, P. P. D., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100198 · Cited by 24

From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis

Alrafiah, A. (2018) · In Vivo · doi:10.21873/invivo.11339 · Cited by 28

Genetic architecture of motor neuron diseases

Chaudhary, R., Agarwal, V., Rehman, M., Kaushik, A. S., & Mishra, V. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.120099 · Cited by 24

RNA Dysregulation in Diseases of Motor Neurons

Ibrahim, F., Nakaya, T., & Mourelatos, Z. (2011) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130307 · Cited by 24

Analysis of spinal and muscle pathology in transgenic mice overexpressing wild-type and ALS-linked mutant MATR3

Moloney, C. M., Rayaprolu, S., Howard, J. C., Fromholt, S., Brown, H. H., Collins, M., Cabrera, M., Duffy, C., Siemienski, Z. B., Miller, D., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0631-0 · Cited by 22

Meta-analysis of Genetic Modifiers Reveals Candidate Dysregulated Pathways in Amyotrophic Lateral Sclerosis

Yanagi, K. S., Wu, Z. J., Amaya, J., Chapkis, N., Duffy, A., Hajdarovic, K. H., Held, A., Mathur, A. D., Russo, K., Ryan, V. H., et al. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.10.033 · Cited by 22

TDP-43 and frontotemporal dementia

Hu, W. T., & Grossman, M. (2009) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-009-0052-3 · Cited by 22

Familial ALS with G298S Mutation in TARDBP: A Comparison of CSF Tau Protein Levels with those in Sporadic ALS

Nozaki, I., Arai, M., Takahashi, K., Hamaguchi, T., Yoshikawa, H., Muroishi, T., Noguchi‐Shinohara, M., Ito, H., Itokawa, M., Akiyama, H., et al. (2010) · Internal Medicine · doi:10.2169/internalmedicine.49.3300 · Cited by 22

TARDBP gene mutations among Chinese patients with sporadic amyotrophic lateral sclerosis

Huang, R., Fang, D., Ma, M., Guo, X., Zhao, B., Zeng, Y., Zhou, D., Yang, Y., & Shang, H. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.07.007 · Cited by 21

Familial Amyotrophic Lateral Sclerosis-linked Mutations in Profilin 1 Exacerbate TDP-43-induced Degeneration in the Retina of Drosophila melanogaster through an Increase in the Cytoplasmic Localization of TDP-43

Matsukawa, K., Hashimoto, T., Matsumoto, T., Ihara, R., Chihara, T., Miura, M., Wakabayashi, T., & Iwatsubo, T. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.729152 · Cited by 22

The optineurin/TIA1 pathway inhibits aberrant stress granule formation and reduces ubiquitinated TDP-43

Kakihana, T., Takahashi, M., Katsuragi, Y., Yamashita, S., Sango, J., Kanki, T., Onodera, O., & Fujii, M. (2021) · iScience · doi:10.1016/j.isci.2021.102733 · Cited by 20

Genomic medicine and neurological disease

Boone, P. M., Wiszniewski, W. K., & Lupski, J. R. (2011) · Human Genetics · doi:10.1007/s00439-011-1001-1 · Cited by 19

IκB kinase phosphorylates cytoplasmic TDP-43 and promotes its proteasome degradation

Iguchi, Y., Takahashi, Y., Li, J., Araki, K., Amakusa, Y., Kawakami, Y., Kobayashi, K., Yokoi, S., & Katsuno, M. (2023) · The Journal of Cell Biology · doi:10.1083/jcb.202302048 · Cited by 20

The Pathological Phenotypes of Human TDP-43 Transgenic Mouse Models Are Independent of Downregulation of Mouse Tdp-43

Xu, Y.-F., Prudencio, M., Hubbard, J., Tong, J., Whitelaw, E. C., Jansen‐West, K. R., Stetler, C. T., Cao, X., Song, J. I., & Zhang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069864 · Cited by 20

Protein Misdirection Inside and Outside Motor Neurons in Amyotrophic Lateral Sclerosis (ALS): A Possible Clue for Therapeutic Strategies

Ido, A., Fukuyama, H., & Urushitani, M. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12106980 · Cited by 20

Overexpression of ter94, Drosophila VCP, improves motor neuron degeneration induced by knockdown of TBPH, Drosophila TDP-43.

Kushimura, Y., Tokuda, T., Azuma, Y., Yamamoto, I., Mizuta, I., Mizuno, T., Nakagawa, M., Ueyama, M., Nagai, Y., Yoshida, H., et al. (2018) · Europe PMC (PubMed Central) · Cited by 20

ALS-linked mutant TDP-43 in oligodendrocytes induces oligodendrocyte damage and exacerbates motor dysfunction in mice

Horiuchi, M., Watanabe, S., Komine, O., Takahashi, E., Kaneko, K., Itohara, S., Shimada, M., Ogi, T., & Yamanaka, K. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01893-x · Cited by 22

CRISPR–Cas technologies in neurodegenerative disorders: mechanistic insights, therapeutic potential, and translational challenges

Yashooa, R. K., Nabi, A. Q., Smail, S. W., Azeez, S. S., Nooh, W. A., Mustafa, S. A., Al-Farha, A. A.-B., Capitanio, N., & Shekha, M. S. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2025.1737468 · Cited by 21

TDP-43 proteinopathy in familial motor neurone disease with TARDBP A315T mutation: a case report

Cairns, N. J., Perrin, R. J., Schmidt, R. E., Gru, A. A., Green, K. G., Carter, D. J., Taylor-Reinwald, L., Morris, J. C., Gitcho, M. A., & Baloh, R. H. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01121.x · Cited by 19

Reappraisal of the anatomical spreading and propagation hypothesis about TDP‐43 aggregation in amyotrophic lateral sclerosis and frontotemporal lobar degeneration

Riku, Y. (2020) · Neuropathology · doi:10.1111/neup.12644 · Cited by 19

Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection

Blasco, H., Patin, F., Andres, C. R., Corcia, P., & Gordon, P. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1202919 · Cited by 19

Moving toward a predictive and personalized clinical approach in amyotrophic lateral sclerosis: novel developments and future directions in diagnosis, genetics, pathogenesis and therapies

Nefussy, B., & Drory, V. E. (2010) · The EPMA Journal · doi:10.1007/s13167-010-0027-0 · Cited by 18

Changes in TDP-43 expression in development, aging, and in the neurofilament light protein knockout mouse

Liu, Y., Atkinson, R. A. K., Fernández-Martos, C. M., Kirkcaldie, M., Cui, H., Vickers, J. C., & King, A. E. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.001 · Cited by 19

SecinH3 Attenuates TDP‐43 p.Q331K‐Induced Neuronal Toxicity by Suppressing Endoplasmic Reticulum Stress and Enhancing Autophagic Flux

Hu, W., Liu, X., Wang, S., Sun, G., Zhao, R., & Lu, H. (2018) · IUBMB Life · doi:10.1002/iub.1951 · Cited by 19

A behavioral screen for mediators of age-dependent TDP-43 neurodegeneration identifies SF2/SRSF1 among a group of potent suppressors in both neurons and glia

Azpurua, J., Elkarim, E. A., Tranquille, M., & Dubnau, J. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009882 · Cited by 17

Stress Granule Homeostasis, Aberrant Phase Transition, and Amyotrophic Lateral Sclerosis

Li, Z., Liu, X., & Liu, M. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00262 · Cited by 17

The Emerging Use ofIn VivoOptical Imaging in the Study of Neurodegenerative Diseases

Patterson, A. P., Booth, S. A., & Saba, R. (2014) · BioMed Research International · doi:10.1155/2014/401306 · Cited by 17

Potential new complication in drug therapy development for amyotrophic lateral sclerosis

Garbuzova-Davis, S. N., Thomson, A., Kurien, C., Shytle, R. D., & Sanberg, P. R. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1207530 · Cited by 16

The hnRNP-Htt axis regulates necrotic cell death induced by transcriptional repression through impaired RNA splicing

Mao, Y., Tamura, T., Yuki, Y., Abe, D., Tamada, Y., Imoto, S., Tanaka, H., Homma, H., Tagawa, K., Miyano, S., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.101 · Cited by 17

MicroRNA expression in animal models of amyotrophic lateral sclerosis and potential therapeutic approaches

Peplow, P., & Martinez, B. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.322431 · Cited by 16

TARDBP mutation associated with semantic variant primary progressive aphasia, case report and review of the literature

González‐Sánchez, M., Puertas‐Martín, V., Esteban‐Pérez, J., García‐Redondo, A., Borrego‐Hernández, D., Méndez-Guerrero, A., Velasco, S. L., Martín, A. H.-S., Cordero-Vázquez, P., Herrero-Manso, M. C., et al. (2018) · Neurocase · doi:10.1080/13554794.2019.1581225 · Cited by 16

Gene Therapy Overexpressing Neuregulin 1 Type I in Combination With Neuregulin 1 Type III Promotes Functional Improvement in the SOD1G93A ALS Mice

Mòdol‐Caballero, G., Herrando‐Grabulosa, M., Verdés, S., García-Lareu, B., Hernández, N., Francos-Quijorna, I., López‐Vales, R., Bosch, A., & Navarro, X. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.693309 · Cited by 16

Pathophysiology of Amyotrophic Lateral Sclerosis

Fabian, H., Clara, M., & Alvaro, G. (2013) · InTech eBooks · doi:10.5772/56562 · Cited by 17

TDP-43 differentially propagates to induce antero- and retrograde degeneration in the corticospinal circuits in mouse focal ALS models

Tsuboguchi, S., Nakamura, Y., Ishihara, T., Kato, T., Sato, T., Koyama, A., Mori, H., Koike, Y. M., Onodera, O., & Ueno, M. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02615-8 · Cited by 14

Multidisciplinary Interventions in Motor Neuron Disease

Williams, U. E., Philip-Ephraim, E. E., & Oparah, S. K. (2014) · Journal of Neurodegenerative Diseases · doi:10.1155/2014/435164 · Cited by 14

p.N345K mutation in TARDBP in a patient with familial amyotrophic lateral sclerosis: An autopsy case

Takeda, T., Iijima, M., Shimizu, Y., Yoshizawa, H., Miyashiro, M., Onizuka, H., Yamamoto, T., Nishiyama, A., Suzuki, N., Aoki, M., et al. (2019) · Neuropathology · doi:10.1111/neup.12559 · Cited by 14

Pathogenic TDP-43 in amyotrophic lateral sclerosis

Chong, Z. Z., & Souayah, N. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104351 · Cited by 13

Early-Onset Alopecia and Amyotrophic Lateral Sclerosis: A Cohort Study

Fondell, E., Fitzgerald, K. C., Falcone, G. J., O’Reilly, É. J., & Ascherio, A. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt096 · Cited by 14

Characterization of the upstream and intron promoters of the gene encoding TAR DNA-binding protein

Hasegawa-Ogawa, M., & Okano, H. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-88015-y · Cited by 13

Clinical Overview and Phenomenology of Movement Disorders

Fahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50004-8 · Cited by 12

Neuropathological features of J apanese familial amyotrophic lateral sclerosis with p. N 352 S mutation in TARDBP

Homma, T., Nagaoka, U., Kawata, A., Mochizuki, Y., Kawakami, H., Maruyama, H., Matsubara, S., & Komori, T. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12090 · Cited by 12

Minor splicing pathway is not minor any more: Implications for the pathogenesis of motor neuron diseases

Onodera, O., Ishihara, T., Shiga, A., Ariizumi, Y., Yokoseki, A., & Nishizawa, M. (2013) · Neuropathology · doi:10.1111/neup.12070 · Cited by 9

Biomarkers for brain disorders

Ward, M. A., & Schofield, E. (2010) · Therapy · doi:10.2217/thy.10.31 · Cited by 9

Expression of hepatocyte growth factor in the skin of amyotrophic lateral sclerosis

Nomura, M., Oketa, Y., Yasui, K., Ishikawa, H., & Ono, S. (2011) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2011.01579.x · Cited by 9

TARDBP mutations are not a frequent cause of ALS in Finnish patients.

Mentula, H.-K., Tuovinen, L., Penttilä, S., Suominen, T., Udd, B., & Palmio, J. (2012) · Europe PMC (PubMed Central) · Cited by 9

What is the key player in TDP ‐43 pathology in ALS : Disappearance from the nucleus or inclusion formation in the cytoplasm?

Onodera, O., Sugai, A., Konno, T., Tada, M., Koyama, A., & Nishizawa, M. (2013) · Neurology and Clinical Neuroscience · doi:10.1002/ncn3.9 · Cited by 8

A novel S379A TARDBP mutation associated to late-onset sporadic ALS

Sprovieri, T., Ungaro, C., Perrone, B., Naimo, G. D., Spataro, R., Cavallaro, S., Bella, V. L., & Conforti, F. L. (2019) · Neurological Sciences · doi:10.1007/s10072-019-03943-y · Cited by 8

Absence of TARDBP Gene Mutations in an Italian Series of Patients with Frontotemporal Lobar Degeneration

Gallone, S., Giordana, M. T., Scarpini, E. A., Rainero, I., Rubino, E., Fenoglio, P., Galimberti, D., Grifoni, S., Venturelli, E., Acutis, P. L., et al. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000241876 · Cited by 9

Genetic Association Analysis between TDP-43 Polymorphisms and Alzheimer’s Disease in a Japanese Population

Shibata, N., Ohnuma, T., Baba, H., & Arai, H. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000251194 · Cited by 8

An autopsy case of familial amyotrophic lateral sclerosis with a TARDBP Q343R mutation

Okamoto, K., Fujita, Y., Hoshino, E., Tamura, Y., Fukuda, T., Hasegawa, M., & Takatama, M. (2015) · Neuropathology · doi:10.1111/neup.12209 · Cited by 8

Clinical overview and phenomenology of movement disorders

Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00001-9 · Cited by 10

Dementia and the TAR DNA Binding Protein 43

Josephs, K. A. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.112 · Cited by 6

Prediction and verification of the AD-FTLD common pathomechanism based on dynamic molecular network analysis

Jin, M., Jin, X., Homma, H., Fujita, K., Tanaka, H., Murayama, S., Akatsu, H., Tagawa, K., & Okazawa, H. (2021) · Communications Biology · doi:10.1038/s42003-021-02475-6 · Cited by 5

Clinical overview and phenomenology of movement disorders

Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00001-9 · Cited by 6

Experimental models of prion‐like protein propagation

Hasegawa, M. (2020) · Neuropathology · doi:10.1111/neup.12656 · Cited by 5

Testing of the therapeutic efficacy and safety of AMPA receptor RNA aptamers in an ALS mouse model

Akamatsu, M., Yamashita, T., Teramoto, S., Huang, Z., Lynch, J., Toda, T., Niu, L., & Kwak, S. (2022) · Life Science Alliance · doi:10.26508/lsa.202101193 · Cited by 5

Advantages and Pitfalls in Experimental Models Of ALS

Boido, M., Buschini, E., Piras, A., Spigolon, G., Valsecchi, V., Mazzini, L., & Vercelli, A. (2012) · InTech eBooks · doi:10.5772/31380 · Cited by 5

The clinical and pathological spectrum of TDP-43 associated ALS

Onodera, O., Yokoseki, A., Tan, C., Ishihara, T., Nishiira, Y., Toyoshima, Y., Kakita, A., Nishizawa, M., & Takahashi, H. (2010) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.50.940

TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis

Kabashi, E., Valdmanis, P. N., Dion, P., Spiegelman, D., McConkey, B. J., Velde, C. V., Bouchard, J.-P., Lacomblez, L., Pochigaeva, K., Salachas, F., et al. (2008) · Nature Genetics · doi:10.1038/ng.132 · Cited by 1,544

TDP-43 M311V mutation in familial amyotrophic lateral sclerosis

Lemmens, R., Race, V., Hersmus, N., Matthijs, G., Bosch, L. V. D., Damme, P. V., Dubois, B., Boonen, S. E., Goris, A., & Robberecht, W. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.157677 · Cited by 57

Correspondence to:

Williams, K. L., Durnall, J. C., Thoeng, A., Warraich, S. T., Nicholson, G. A., Blair, I. P., Neuroscience, N., Australia, S. S., Blair, D. I. P., Laboratory, N., et al. (2009)

TARDBP (TDP‐43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations

Bo, R. D., Ghezzi, S., Corti, S. P., Pandolfo, M., Ranieri, M., Santoro, D., Ghione, I., Prelle, A. C., Orsetti, V., Mancuso, M., et al. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02574.x · Cited by 108